Some of the top hits identified by our screen, including PTEN, CSK, NF1, and TSC1/2 had previously been identified by a CRISPR-Cas9 screen that was performed with the ERα+ breast cancer cell lines MCF7 and T47D (32). This evidence concerns the gene ESR1 and breast carcinoma.